FMO5 and cardiovascular disorder: In the context of cardiovascular disease, a genetic polymorphism of NADPH oxidase seems to be vital since ROS overproduction, associated with inflammation and metabolic dysfunction, may contribute to atherosclerotic plaque instability and by that means be a trigger of abrupt manifestation of cardiovascular disease [5,6,7].